LabCorp’s drug development business, Covance, has acquired GlobalCare, a provider of patient-centric decentralized clinical trials support services. This acquisition will expand Covance’s decentralized clinical trials capabilities globally, enabling recruitment and increasing access to trials. Covance will leverage GlobalCare’s mobile healthcare services, site staffing support, patient transport assistance and contracted central pharmacy services. GlobalCare’s customers will have access ...